Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics.
第一作者:
Adam J,Nelson
第一单位:
Duke Clinical Research Institute, Durham, NC; University of Adelaide, Adelaide, South Australia, Australia. Electronic address: a.nelson@duke.edu.
作者:
主题词
人类(Humans);糖尿病, 2型(Diabetes Mellitus, Type 2);男(雄)性(Male);女(雌)性(Female);美国(United States);中年人(Middle Aged);动脉粥样硬化(Atherosclerosis);老年人(Aged);停止治疗(Withholding Treatment);降血糖药(Hypoglycemic Agents)
DOI
10.1016/j.ahj.2024.12.006
PMID
39716628
发布时间
2025-02-23
- 浏览0
American heart journal
51-57页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文